UFP Technologies, Inc. (UFPT)
USD 193.62
(-8.15%)
USD 193.62
(-8.15%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 58.08 Million USD | 26.84% |
| 2022 | 45.79 Million USD | 55.35% |
| 2021 | 29.48 Million USD | 7.23% |
| 2020 | 27.49 Million USD | -6.01% |
| 2019 | 29.25 Million USD | 5.38% |
| 2018 | 27.75 Million USD | 16.41% |
| 2017 | 23.84 Million USD | -1.08% |
| 2016 | 24.1 Million USD | 0.4% |
| 2015 | 24 Million USD | 0.68% |
| 2014 | 23.84 Million USD | 2.61% |
| 2013 | 23.24 Million USD | 7.94% |
| 2012 | 21.53 Million USD | 0.77% |
| 2011 | 21.36 Million USD | 5.59% |
| 2010 | 20.23 Million USD | 9.15% |
| 2009 | 18.53 Million USD | -1.51% |
| 2008 | 18.82 Million USD | 20.95% |
| 2007 | 15.56 Million USD | 9.73% |
| 2006 | 14.18 Million USD | 14.1% |
| 2005 | 12.43 Million USD | 2.67% |
| 2004 | 12.1 Million USD | 11.82% |
| 2003 | 10.82 Million USD | -6.97% |
| 2002 | 11.63 Million USD | -14.73% |
| 2001 | 13.64 Million USD | -21.18% |
| 2000 | 17.31 Million USD | 24.58% |
| 1999 | 13.9 Million USD | 17.8% |
| 1998 | 11.8 Million USD | 6.31% |
| 1997 | 11.1 Million USD | 19.35% |
| 1996 | 9.3 Million USD | 12.05% |
| 1995 | 8.3 Million USD | -8.79% |
| 1994 | 9.1 Million USD | 40.0% |
| 1993 | 6.5 Million USD | 10.17% |
| 1992 | 5.9 Million USD | 3.51% |
| 1991 | 5.7 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 15.78 Million USD | 13.59% |
| 2024 Q2 | 13.9 Million USD | -0.09% |
| 2024 Q1 | 13.91 Million USD | 6.05% |
| 2023 Q2 | 12.29 Million USD | -5.44% |
| 2023 Q1 | 13 Million USD | 9.4% |
| 2023 FY | 58.08 Million USD | 26.84% |
| 2023 Q3 | 12.46 Million USD | 1.37% |
| 2023 Q4 | 13.11 Million USD | 5.22% |
| 2022 FY | 45.79 Million USD | 55.35% |
| 2022 Q4 | 11.88 Million USD | 0.56% |
| 2022 Q3 | 11.82 Million USD | -2.12% |
| 2022 Q2 | 12.07 Million USD | 20.65% |
| 2022 Q1 | 10.01 Million USD | 23.03% |
| 2021 Q1 | 7.3 Million USD | 16.26% |
| 2021 Q4 | 8.13 Million USD | 19.56% |
| 2021 FY | 29.48 Million USD | 7.23% |
| 2021 Q3 | 6.8 Million USD | -5.84% |
| 2021 Q2 | 7.22 Million USD | -1.11% |
| 2020 FY | 27.49 Million USD | -6.01% |
| 2020 Q1 | 7.75 Million USD | 10.35% |
| 2020 Q2 | 6.66 Million USD | -14.02% |
| 2020 Q3 | 6.79 Million USD | 1.89% |
| 2020 Q4 | 6.28 Million USD | -7.42% |
| 2019 Q1 | 7.24 Million USD | 0.5% |
| 2019 Q2 | 7.79 Million USD | 7.66% |
| 2019 Q3 | 7.18 Million USD | -7.9% |
| 2019 Q4 | 7.02 Million USD | -2.2% |
| 2019 FY | 29.25 Million USD | 5.38% |
| 2018 Q4 | 7.2 Million USD | 10.2% |
| 2018 FY | 27.75 Million USD | 16.41% |
| 2018 Q3 | 6.54 Million USD | -11.81% |
| 2018 Q1 | 6.59 Million USD | 14.15% |
| 2018 Q2 | 7.41 Million USD | 12.52% |
| 2017 Q4 | 5.77 Million USD | 1.44% |
| 2017 FY | 23.84 Million USD | -1.08% |
| 2017 Q2 | 6.06 Million USD | -4.04% |
| 2017 Q1 | 6.31 Million USD | 10.73% |
| 2017 Q3 | 5.69 Million USD | -6.07% |
| 2016 Q1 | 5.9 Million USD | 5.33% |
| 2016 FY | 24.1 Million USD | 0.4% |
| 2016 Q3 | 6.02 Million USD | -6.85% |
| 2016 Q4 | 5.7 Million USD | -5.36% |
| 2016 Q2 | 6.47 Million USD | 9.59% |
| 2015 Q4 | 5.6 Million USD | 0.02% |
| 2015 FY | 24 Million USD | 0.68% |
| 2015 Q2 | 6.77 Million USD | 12.48% |
| 2015 Q1 | 6.02 Million USD | 5.96% |
| 2015 Q3 | 5.6 Million USD | -17.3% |
| 2014 Q4 | 5.68 Million USD | -3.17% |
| 2014 Q3 | 5.87 Million USD | -9.2% |
| 2014 Q2 | 6.46 Million USD | 10.83% |
| 2014 Q1 | 5.83 Million USD | 5.31% |
| 2014 FY | 23.84 Million USD | 2.61% |
| 2013 Q2 | 6.07 Million USD | 2.17% |
| 2013 FY | 23.24 Million USD | 7.94% |
| 2013 Q1 | 5.94 Million USD | 8.8% |
| 2013 Q3 | 5.67 Million USD | -6.52% |
| 2013 Q4 | 5.54 Million USD | -2.44% |
| 2012 Q1 | 5.51 Million USD | 16.46% |
| 2012 Q3 | 5.15 Million USD | -4.25% |
| 2012 Q4 | 5.46 Million USD | 5.99% |
| 2012 Q2 | 5.38 Million USD | -2.42% |
| 2012 FY | 21.53 Million USD | 0.77% |
| 2011 FY | 21.36 Million USD | 5.59% |
| 2011 Q4 | 4.73 Million USD | -9.22% |
| 2011 Q3 | 5.21 Million USD | -8.21% |
| 2011 Q2 | 5.68 Million USD | 16.25% |
| 2011 Q1 | 4.89 Million USD | 3.35% |
| 2010 FY | 20.23 Million USD | 9.15% |
| 2010 Q1 | 5.01 Million USD | 7.52% |
| 2010 Q2 | 5.38 Million USD | 7.49% |
| 2010 Q3 | 5.1 Million USD | -5.28% |
| 2010 Q4 | 4.73 Million USD | -7.24% |
| 2009 FY | 18.53 Million USD | -1.51% |
| 2009 Q2 | 4.41 Million USD | 2.45% |
| 2009 Q1 | 4.31 Million USD | 20.55% |
| 2009 Q4 | 4.66 Million USD | -8.07% |
| 2009 Q3 | 5.07 Million USD | 14.83% |
| 2008 FY | 18.82 Million USD | 20.95% |
| 2008 Q2 | 4.98 Million USD | 1.26% |
| 2008 Q1 | 4.92 Million USD | 18.9% |
| 2008 Q4 | 3.57 Million USD | -33.05% |
| 2008 Q3 | 5.34 Million USD | 7.17% |
| 2007 Q4 | 4.13 Million USD | 10.31% |
| 2007 FY | 15.56 Million USD | 9.73% |
| 2007 Q3 | 3.75 Million USD | -7.52% |
| 2007 Q2 | 4.05 Million USD | 12.31% |
| 2007 Q1 | 3.61 Million USD | 7.51% |
| 2006 FY | 14.18 Million USD | 14.1% |
| 2006 Q4 | 3.36 Million USD | 2.04% |
| 2006 Q3 | 3.29 Million USD | -14.95% |
| 2006 Q2 | 3.87 Million USD | 5.88% |
| 2006 Q1 | 3.65 Million USD | 24.43% |
| 2005 Q3 | 3.06 Million USD | -9.02% |
| 2005 Q4 | 2.93 Million USD | -4.22% |
| 2005 Q2 | 3.37 Million USD | 10.59% |
| 2005 Q1 | 3.05 Million USD | 1.08% |
| 2005 FY | 12.43 Million USD | 2.67% |
| 2004 Q4 | 3.01 Million USD | 0.92% |
| 2004 FY | 12.1 Million USD | 11.82% |
| 2004 Q2 | 3.11 Million USD | 4.59% |
| 2004 Q1 | 2.98 Million USD | 14.89% |
| 2004 Q3 | 2.98 Million USD | -4.12% |
| 2003 Q1 | 2.68 Million USD | 17.39% |
| 2003 FY | 10.82 Million USD | -6.97% |
| 2003 Q4 | 2.59 Million USD | -10.7% |
| 2003 Q3 | 2.9 Million USD | 10.06% |
| 2003 Q2 | 2.64 Million USD | -1.69% |
| 2002 Q1 | 3.15 Million USD | -4.55% |
| 2002 Q4 | 2.28 Million USD | -25.27% |
| 2002 FY | 11.63 Million USD | -14.73% |
| 2002 Q3 | 3.06 Million USD | -2.36% |
| 2002 Q2 | 3.13 Million USD | -0.57% |
| 2001 Q3 | 3.3 Million USD | 2.05% |
| 2001 FY | 13.64 Million USD | -21.18% |
| 2001 Q1 | 3.8 Million USD | -5.2% |
| 2001 Q2 | 3.23 Million USD | -14.92% |
| 2001 Q4 | 3.3 Million USD | 0.0% |
| 2000 Q4 | 4.01 Million USD | -10.36% |
| 2000 Q3 | 4.47 Million USD | -0.27% |
| 2000 Q2 | 4.48 Million USD | 3.47% |
| 2000 Q1 | 4.33 Million USD | 11.25% |
| 2000 FY | 17.31 Million USD | 24.58% |
| 1999 Q3 | 3.4 Million USD | 0.0% |
| 1999 Q2 | 3.4 Million USD | 3.03% |
| 1999 Q1 | 3.3 Million USD | 6.45% |
| 1999 FY | 13.9 Million USD | 17.8% |
| 1999 Q4 | 3.9 Million USD | 14.71% |
| 1998 Q1 | 2.8 Million USD | 0.0% |
| 1998 Q2 | 2.8 Million USD | 0.0% |
| 1998 Q3 | 3.1 Million USD | 10.71% |
| 1998 Q4 | 3.1 Million USD | 0.0% |
| 1998 FY | 11.8 Million USD | 6.31% |
| 1997 FY | 11.1 Million USD | 19.35% |
| 1997 Q2 | 2.8 Million USD | 3.7% |
| 1997 Q3 | 2.9 Million USD | 3.57% |
| 1997 Q1 | 2.7 Million USD | 8.0% |
| 1997 Q4 | 2.8 Million USD | -3.45% |
| 1996 Q2 | 2.4 Million USD | 20.0% |
| 1996 FY | 9.3 Million USD | 12.05% |
| 1996 Q3 | 2.4 Million USD | 0.0% |
| 1996 Q4 | 2.5 Million USD | 4.17% |
| 1996 Q1 | 2 Million USD | -4.76% |
| 1995 Q3 | 2.1 Million USD | 5.0% |
| 1995 Q4 | 2.1 Million USD | 0.0% |
| 1995 Q1 | 2.1 Million USD | -19.23% |
| 1995 Q2 | 2 Million USD | -4.76% |
| 1995 FY | 8.3 Million USD | -8.79% |
| 1994 Q3 | 2 Million USD | -13.04% |
| 1994 Q1 | 2.1 Million USD | 107.09% |
| 1994 Q2 | 2.3 Million USD | 9.52% |
| 1994 FY | 9.1 Million USD | 40.0% |
| 1994 Q4 | 2.6 Million USD | 30.0% |
| 1993 Q1 | - USD | 100.0% |
| 1993 Q2 | - USD | 0.0% |
| 1993 Q3 | - USD | 0.0% |
| 1993 Q4 | -29.6 Million USD | 0.0% |
| 1993 FY | 6.5 Million USD | 10.17% |
| 1992 Q3 | - USD | 0.0% |
| 1992 FY | 5.9 Million USD | 3.51% |
| 1992 Q4 | -28.1 Million USD | 0.0% |
| 1992 Q1 | - USD | 100.0% |
| 1992 Q2 | - USD | 0.0% |
| 1991 Q4 | -26.8 Million USD | 0.0% |
| 1991 FY | 5.7 Million USD | 0.0% |
| 1991 Q1 | - USD | 0.0% |
| 1991 Q2 | - USD | 0.0% |
| 1991 Q3 | - USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -417.543% |
| Cerus Corporation | 143.15 Million USD | 59.422% |
| OrthoPediatrics Corp. | 137.01 Million USD | 57.605% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -411.308% |
| Talis Biomedical Corporation | 67.18 Million USD | 13.54% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -132.859% |
| Inogen, Inc. | 236.08 Million USD | 75.395% |
| Spectral AI, Inc. | 20.86 Million USD | -178.417% |
| Nano-X Imaging Ltd. | 55.99 Million USD | -3.736% |
| CVRx, Inc. | 76.14 Million USD | 23.71% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -1546.515% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -365.121% |
| Orthofix Medical Inc. | 667.42 Million USD | 91.297% |
| Venus Concept Inc. | 80.47 Million USD | 27.818% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | -2.671% |
| Bioventus Inc. | 409.91 Million USD | 85.829% |
| BrainsWay Ltd. | 28.01 Million USD | -107.327% |
| Envoy Medical, Inc. | 17.89 Million USD | -224.556% |
| electroCore, Inc. | 32.03 Million USD | -81.352% |
| IceCure Medical Ltd | 16.87 Million USD | -244.211% |
| Lucid Diagnostics Inc. | 42.43 Million USD | -36.899% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -229.433% |
| MaxCyte, Inc. | 84.84 Million USD | 31.535% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -368.016% |
| Nexalin Technology, Inc. | 5.78 Million USD | -904.764% |
| PAVmed Inc | 64.82 Million USD | 10.394% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | -13.726% |
| RxSight, Inc. | 103.85 Million USD | 44.065% |
| Sight Sciences, Inc. | 126.44 Million USD | 54.061% |
| SI-BONE, Inc. | 156.35 Million USD | 62.847% |
| TELA Bio, Inc. | 84.18 Million USD | 31.0% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 17.082% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 71.436% |
| LivaNova PLC | 843.54 Million USD | 93.114% |
| 908 Devices Inc. | 68.08 Million USD | 14.675% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 87.988% |
| Nemaura Medical Inc. | 7.13 Million USD | -713.708% |
| NeuroPace, Inc. | 75.29 Million USD | 22.852% |
| LENSAR, Inc. | 33.33 Million USD | -74.253% |
| Apyx Medical Corporation | 51.01 Million USD | -13.86% |
| Cutera, Inc. | 197.72 Million USD | 70.621% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -134.409% |
| BioSig Technologies, Inc. | 28.53 Million USD | -103.607% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 69.662% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | -61.09% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 93.055% |
| Axonics, Inc. | 270.2 Million USD | 78.502% |
| Outset Medical, Inc. | 198.77 Million USD | 70.776% |
| IRIDEX Corporation | 31.81 Million USD | -82.589% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 67.768% |
| IRadimed Corporation | 30.12 Million USD | -92.841% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -580.837% |
| INVO Bioscience, Inc. | 7.85 Million USD | -639.677% |
| Telesis Bio, Inc. | 63.48 Million USD | 8.505% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 40.998% |
| Varex Imaging Corporation | 224.8 Million USD | 74.16% |
| Quipt Home Medical Corp. | 148.66 Million USD | 60.927% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -395.513% |
| Pulmonx Corporation | 112.68 Million USD | 48.451% |
| Dynatronics Corporation | 9.9 Million USD | -486.282% |
| Modular Medical, Inc. | 17.52 Million USD | -231.388% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -187.754% |
| Semler Scientific, Inc. | 38.94 Million USD | -49.16% |
| InMode Ltd. | 215.68 Million USD | 73.067% |
| Bruker Corporation | 1.07 Billion USD | 94.603% |
| Cytosorbents Corporation | 48.33 Million USD | -20.175% |
| DexCom, Inc. | 1.69 Billion USD | 96.565% |
| Align Technology, Inc. | 2.07 Billion USD | 97.203% |
| Viveve Medical, Inc. | 22.17 Million USD | -161.981% |
| ZimVie Inc. | 275.12 Million USD | 78.886% |
| Movano Inc. | 29.69 Million USD | -95.652% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 57.683% |
| Nexalin Technology, Inc. | 5.78 Million USD | -904.764% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -1546.515% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 90.333% |
| Profound Medical Corp. | 33.6 Million USD | -72.868% |
| Insulet Corporation | 939.9 Million USD | 93.82% |
| enVVeno Medical Corporation | 25.23 Million USD | -130.165% |
| Surmodics, Inc. | 98.69 Million USD | 41.144% |
| iCAD, Inc. | 22.22 Million USD | -161.368% |
| Nuwellis, Inc. | 22.61 Million USD | -156.883% |
| Biotricity, Inc. | 17.18 Million USD | -238.03% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 86.972% |
| Aethlon Medical, Inc. | 12.27 Million USD | -373.133% |
| InspireMD, Inc. | 22.95 Million USD | -153.111% |
| PAVmed Inc. | 64.82 Million USD | 10.394% |
| BIOLASE, Inc. | 34.66 Million USD | -67.592% |
| Beyond Air, Inc. | 61.7 Million USD | 5.853% |
| FONAR Corporation | 28.6 Million USD | -103.075% |
| AxoGen, Inc. | 149.33 Million USD | 61.102% |
| Vivani Medical, Inc. | 26.96 Million USD | -115.424% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 67.198% |
| Inari Medical, Inc. | 448.59 Million USD | 87.051% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -1078.85% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -819.379% |
| Tenon Medical, Inc. | 16.96 Million USD | -242.344% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -685.73% |
| Co-Diagnostics, Inc. | 44.1 Million USD | -31.713% |
| AdaptHealth Corp. | 1.07 Billion USD | 94.611% |
| Sintx Technologies, Inc. | 15.2 Million USD | -282.139% |
| NanoVibronix, Inc. | 4.97 Million USD | -1068.088% |
| Quanterix Corporation | 118.1 Million USD | 50.814% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -395.513% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -302.223% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 85.207% |
| TransMedics Group, Inc. | 182.82 Million USD | 68.226% |
| ReWalk Robotics Ltd. | 28.06 Million USD | -106.98% |
| NeuroMetrix, Inc. | 11.09 Million USD | -423.375% |
| Hyperfine, Inc. | 52.87 Million USD | -9.867% |
| Establishment Labs Holdings Inc. | 172 Million USD | 66.228% |
| Biomerica, Inc. | 6.97 Million USD | -732.459% |
| Bone Biologics Corporation | 9.42 Million USD | -516.113% |
| AVITA Medical, Inc. | 80.77 Million USD | 28.089% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -463.357% |
| Silk Road Medical, Inc | 186.35 Million USD | 68.829% |